Snowden Capital Advisors’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-9,559
Closed -$470K 1187
2022
Q1
$470K Buy
9,559
+9,483
+12,478% +$501K 0.02% 652
2021
Q4
$4K Sell
76
-5,179
-99% -$285K ﹤0.01% 1771
2021
Q3
$305K Buy
5,255
+437
+9% +$26.9K 0.02% 691
2021
Q2
$305K Buy
4,818
+347
+8% +$22.9K 0.02% 700
2021
Q1
$285K Buy
+4,471
New +$259K 0.02% 648

Other funds holding XRAY

Snowden Capital Advisors's XRAY Position: Q2 2022 in Review

Snowden Capital Advisors sold out of Dentsply Sirona (XRAY) in Q2 2022, closing a stake of 9,559 shares — an estimated $470K sold.

Snowden Capital Advisors first reported a position in XRAY in Q1 2021 and held it in 5 quarters. The position peaked at $470K in Q1 2022. 470 funds tracked by Wall St. Rank hold XRAY as of Q2 2022.

  • Snowden Capital Advisors reported no remaining Dentsply Sirona position as of Q2 2022 after selling out during the quarter.
  • Snowden Capital Advisors sold 9,559 Dentsply Sirona shares in Q2 2022, an estimated $470K.
  • Snowden Capital Advisors first reported a position in Dentsply Sirona in Q1 2021 and held it in 5 quarters.
  • Snowden Capital Advisors's Dentsply Sirona position peaked at $470K in Q1 2022.
  • 470 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2022.

Based on Snowden Capital Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.